Growth in biosciences FUJIFILM Biosciences operates as a global full spectrum supplier to the life sciences market with capabilities spanning life science research, cell and gene therapy, and large-scale biotherapeutics and vaccines production, presenting opportunities to upsell integrated product and service bundles across R&D and manufacturing workflows.

Regulatory ready capacity Manufacturing facilities adhere to cGMP in the USA, Japan, and the Netherlands with ISO and FDA-compliant operations, signaling strong quality and regulatory alignment that can be leveraged to pursue contract development and manufacturing organization (CDMO) opportunities and trusted supplier status with biopharma partners.

Sustainability focus All sites align with the FUJIFILM Sustainability Value Plan 2030, offering a platform to position environmental, social, and governance (ESG) advantages in procurement conversations and to attract customers prioritizing sustainable bioprocessing and responsible supply chains.

Global capabilities As a global supplier with multiple regional facilities and a media optimization center in China, there are cross-regional sales opportunities to support multinational customers needing consistent sourcing, turnkey solutions, and localized service across markets.

Growth potential from portfolio breadth Expanding portfolio across life science discovery, cell and gene therapy, and large-scale biotherapeutics and vaccines production opens doors for bundled offerings, from research reagents to manufacturing support, enabling cross-sell to existing life sciences and biotech clients seeking end-to-end solutions.